{"id":"W2345185915","doi":"10.1016/j.jval.2015.03.1243","title":"Reimbursement Approval of Oncology Drugs In Canada Supported By a Data Package Lacking Phase III Trial Data","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Clinical trial; Crizotinib; Family medicine; Randomized controlled trial; Brentuximab vedotin; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma; Health care; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02847152,0.0005101346,0.001072931,0.002657473,0.00160703,0.005408595,0.002567144,0.002385973,0.00627914],"category_scores_gemma":[0.1088238,0.0008537486,0.001404141,0.005791226,0.001537215,0.001236242,0.001404293,0.002973276,0.0008556801],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06146086,"about_ca_system_score_gemma":0.2622747,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9098052,"about_ca_topic_score_gemma":0.9273525,"domain_scores_codex":[0.9788049,0.007684578,0.00130342,0.000929958,0.00778527,0.003491741],"domain_scores_gemma":[0.8668799,0.05340317,0.01520248,0.004717852,0.0426742,0.01712235],"domain_codex":null,"domain_gemma":"reporting","domain_candidate":"reporting","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.01260193,0.0005150115,0.1040708,0.002219726,0.001032089,0.0003733577,0.0003489012,0.02221336,0.0009027084,0.03756288,0.6832853,0.134874],"study_design_scores_gemma":[0.0126672,0.001688935,0.488834,0.002079544,0.001600775,0.0002545505,0.0004167076,0.04537883,0.002015273,0.007998657,0.4367101,0.0003555415],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.3081667,0.01496885,0.01573366,0.2478321,0.003672113,0.01047186,0.2690996,0.002387085,0.127668],"genre_scores_gemma":[0.8373752,0.00495641,0.01567044,0.03754961,0.001256637,0.002218152,0.0694281,0.0003198352,0.03122557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9715285,"threshold_uncertainty_score":0.4459319,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2159490101535349,"score_gpt":0.3568086925135758,"score_spread":0.1408596823600408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}